Editas Medicine Inc (EDIT)
5.315
+0.10
(+1.82%)
USD |
NASDAQ |
Apr 26, 16:00
5.33
+0.02
(+0.28%)
After-Hours: 20:00
Editas Medicine Net Income (Quarterly): -18.87M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.87M |
| September 30, 2023 | -45.02M |
| June 30, 2023 | -40.29M |
| March 31, 2023 | -49.04M |
| December 31, 2022 | -60.74M |
| September 30, 2022 | -55.73M |
| June 30, 2022 | -53.45M |
| March 31, 2022 | -50.52M |
| December 31, 2021 | -41.44M |
| September 30, 2021 | -39.08M |
| June 30, 2021 | -55.26M |
| March 31, 2021 | -56.73M |
| December 31, 2020 | -62.50M |
| September 30, 2020 | 7.819M |
| June 30, 2020 | -23.57M |
| March 31, 2020 | -37.72M |
| December 31, 2019 | -37.77M |
| September 30, 2019 | -32.94M |
| June 30, 2019 | -33.79M |
| Date | Value |
|---|---|
| March 31, 2019 | -29.25M |
| December 31, 2018 | -25.06M |
| September 30, 2018 | -15.24M |
| June 30, 2018 | -38.72M |
| March 31, 2018 | -30.94M |
| December 31, 2017 | -36.19M |
| September 30, 2017 | -26.60M |
| June 30, 2017 | -26.44M |
| March 31, 2017 | -31.10M |
| December 31, 2016 | -39.38M |
| September 30, 2016 | -21.02M |
| June 30, 2016 | -19.04M |
| March 31, 2016 | -17.74M |
| December 31, 2015 | -12.63M |
| September 30, 2015 | -7.405M |
| June 30, 2015 | -47.57M |
| March 31, 2015 | -5.291M |
| December 31, 2014 | -5.411M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-62.50M
Minimum
Dec 2020
7.819M
Maximum
Sep 2020
-41.40M
Average
-41.44M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 968.80M |
| Moderna Inc | 217.00M |
| Amicus Therapeutics Inc | -33.84M |
| Geron Corp | -51.97M |
| Regeneron Pharmaceuticals Inc | 1.160B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 60.05M |
| Total Expenses (Quarterly) | 84.01M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 103.96M |
| Profit Margin (Quarterly) | -31.43% |
| Earnings Yield | -38.57% |
| Normalized Earnings Yield | -38.57 |